Latest Market News

Platinum Asia Investments Limited has announced a significant restructure via a scheme of arrangement, offering shareholders the chance to exchange shares for units in a new ETF, alongside a potential special dividend. The company has secured court approval and outlined a detailed timetable for the process.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Battery Age Minerals has successfully raised $3 million to fund maiden drilling at its Bleiberg Germanium-Zinc Project in Austria and advance exploration at the El Aguila Gold-Silver Project in Argentina, attracting new investors and reinforcing its strategic position in critical minerals.

Platinum Capital Limited has secured a court date to progress its scheme of arrangement, offering shareholders a swap of shares for ETF units and a potential special dividend. Key dates and financial mechanics have been outlined ahead of the shareholder vote.

Findi Limited is applying for two key licences from the Reserve Bank of India to expand its digital payments footprint, aiming to bridge the gap between cash and digital economies across India.

Enova Mining has launched a focused Phase 2 surface sampling campaign at its East Salinas project in Brazil, aiming to refine high-grade rare earth element drill targets ahead of planned drilling later this month.

Butn Limited has locked in a $100 million senior secured debt facility with Northleaf Capital Partners, marking a pivotal step in its growth strategy and refinancing existing debt.

Warriedar Resources has confirmed significant high-grade antimony mineralisation at its Azure Coast deposit near the Ricciardo gold project, unveiling new potential in the Golden Range belt. The company plans targeted drilling later this year to expand on these promising results.

Washington H. Soul Pattinson has completed a major repurchase of its $450 million convertible notes, retiring nearly all outstanding debt and setting the stage for potential full redemption.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

Helia Group reveals ING Bank Australia will not renew its Lenders Mortgage Insurance contract beyond June 2026, prompting a strategic business review amid evolving market dynamics.

Astron Corporation Limited proposes to shift its corporate domicile from Hong Kong to Australia by establishing a new Australian parent company, Astron Limited. Shareholders and CDI holders will exchange their securities on a two-for-one basis, aligning the group’s structure with its Australian assets and simplifying governance.